BioCryst Pharmaceuticals
BCRX
#4788
Rank
C$2.16 B
Marketcap
$10.47
Share price
2.60%
Change (1 day)
49.78%
Change (1 year)

EPS for BioCryst Pharmaceuticals (BCRX)

EPS in 2023 (TTM): -$1.68

According to BioCryst Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$1.75. In 2022 the company made an earnings per share (EPS) of -$1.86 a decrease over its 2021 EPS that were of -$1.44.

EPS history for BioCryst Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.68-9.47%
2022-$1.8629.13%
2021-$1.44-4.63%
2020-$1.5110.2%
2019-$1.370%
2018-$1.3725.64%
2017-$1.094%
2016-$1.0527.12%
2015-$0.82-13.24%
2014-$0.9523.64%
2013-$0.77-30.38%
2012-$1.10-37.3%
2011-$1.7665.79%
2010-$1.06117.14%
2009-$0.49-46.15%
2008-$0.91-26.97%
2007-$1.24-40.67%
2006-$2.1048.51%
2005-$1.411%
2004-$1.4038.89%
2003-$1.01-25%
2002-$1.34231.03%
2001-$0.41-56.72%
2000-$0.9491.43%
1999-$0.492.94%
1998-$0.48-55.84%
1997-$1.0811.59%
1996-$0.96

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.92-267.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-$10.94 526.40%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.82-52.80%๐Ÿ‡บ๐Ÿ‡ธ USA
-$10.05 475.20%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.13-451.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.35 92.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.89-380.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$16.88 866.40%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.08-38.40%๐Ÿ‡บ๐Ÿ‡ธ USA